Marta Vidaurreta

Author PubWeight™ 10.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One 2012 1.09
2 Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist 2012 1.03
3 Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009 1.00
4 Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. Nephrol Dial Transplant 2012 0.91
5 Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer. Tumour Biol 2012 0.90
6 Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab. Clin Colorectal Cancer 2013 0.90
7 Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis. Anticancer Res 2009 0.88
8 Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C. PLoS One 2013 0.87
9 Telomerase activity as a prognostic factor in colorectal cancer. Onkologie 2005 0.87
10 Circulating tumour cells in locally advanced breast cancer. Clin Transl Oncol 2009 0.85
11 Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients. Clin Transl Oncol 2006 0.80
12 Effect of β-catenin alterations in the prognosis of patients with sporadic colorectal cancer. J Cancer Res Ther 2014 0.78
13 A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis. Anticancer Res 2013 0.75